HOOKIPA Pharma Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported net loss was USD 24.82 million compared to USD 12.31 million a year ago. Basic loss per share from continuing operations was USD 0.22 compared to USD 0.17 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.783 USD | -3.20% | -3.08% | -3.33% |
Jun. 05 | HC Wainwright Adjusts Price Target on HOOKIPA Pharma to $6 From $5, Maintains Buy Rating | MT |
Jun. 04 | Transcript : HOOKIPA Pharma Inc. - Special Call |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.33% | 80.04M | |
+48.79% | 780B | |
+41.76% | 627B | |
+19.43% | 334B | |
+7.18% | 296B | |
+17.60% | 244B | |
-0.41% | 217B | |
+11.54% | 214B | |
+4.53% | 161B | |
-3.92% | 159B |
- Stock Market
- Equities
- HOOK Stock
- News HOOKIPA Pharma Inc.
- HOOKIPA Pharma Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023